Results 41 to 50 of about 54,362 (142)

Comparison of functional exercise capacity, quality of life and respiratory and peripheral muscle strength between patients with stable angina and healthy controls

Journal of International Medical Research, 2020
Objective We aimed to compare functional exercise capacity, respiratory and peripheral muscle strength, pulmonary function and quality of life between patients with stable angina and healthy controls.
Irem Huzmeli, Aysel-Yildiz Ozer, Oguz Akkus, Nihan Katayıfcı, Fatih Sen, Saadet Ufuk Yurdalan, Mine Gulden Polat   +6 more
doaj   +1 more source

CLINICAL AND ECONOMIC EVALUATION OF IVABRADINE USE IN STABLE ANGINA IN TERMS OF REPUBLIC OF BELARUS HEALTH CARE SYSTEM

Фармакоэкономика, 2015
stable angina is a socially significant disease that requires significant financial costs to the health system and patients. In recent years the increased heart rate has been considered as a significant risk factor for poor prognosis in stable angina ...
I. N. Kozhanova, I. S. Romanova, L. N. Gavrilenko, A. V. Patseev, M. M. Sachek   +4 more
doaj  

Effectiveness of a selective If channel inhibitor ivabradine in patients with stable angina

Кардиоваскулярная терапия и профилактика, 2009
Aim. To study clinical effectiveness of ivabradine (7,5 mg twice a day) as a part of combined therapy, and its effects on physical stress (PS) tolerability in patients with Functional Class (FC) II-III stable angina and absolute or relative ...
E. V. Kuleshova
doaj  

The efficacy and safety of coronary sinus reducer in refractory angina: a systematic review and meta-analysis

BMC Cardiovascular Disorders
Background Refractory angina is a challenging medical disorder associated with continuous anginal symptoms that do not respond to medical treatments or revascularization interventions.
Ahmed Elshahat, Muhammad Ashraf Husain, Ahmed Elbataa, Ahmed Farid Gadelmawla, Hamdy A. Makhlouf, Rahma AbdElfattah Ibrahim, Mohammed Sabri Hassanin, Fayed Mohamed Rzk, Ahmed Elmorsy Mohamed, Ahmed Helmi, Moaz Abouelmagd, Ahmed O. Sena, Ahmed Bahnasy, Emad Singer, Ahmed Almahdy Mohamed, Mohamed Yasser Elnaggar, Shereen Mohamed Olama, Mahmoud G. A. Saleh, Esraa A. Shaban, Ahmed Abdelaziz   +19 more
doaj   +1 more source

Management of Stable Angina with Ivabradine as Safe Alternative to Patients with Myasthenia Gravis

Case Reports in Neurological Medicine, 2016
Management of cardiac symptoms in myasthenia gravis (MG) patients can be challenging. The aim of this report is to describe the safe use of ivabradine for stable angina in MG patients. A 48 y.o.
Giuliano Ohde Dalledone, Gustavo Lenci Marques, Renata Dal-Prá Ducci, Arnaldo Laffitte Stier Junior, Cláudia Suemi Kamoi Kay, Lineu Cesar Werneck, Paulo José Lorenzoni, Rosana Herminia Scola   +7 more
doaj   +1 more source

Hypertension is associated with increased mortality in patients with ischaemic heart disease after revascularization with percutaneous coronary intervention – a report from SCAAR

Blood Pressure, 2017
Background: The prognostic role of hypertension on long-term survival after percutaneous coronary intervention (PCI) is limited and inconsistent. We hypothesize that hypertension increases long-term mortality after PCI.
Ott Saluveer, Björn Redfors, Oskar Angerås, Christian Dworeck, Inger Haraldsson, Charlotta Ljungman, Petur Petursson, Jacob Odenstedt, Dan Ioanes, Peter Lundgren, Sebastian Völz, Truls Råmunddal, Bert Andersson, Elmir Omerovic, Niklas Bergh   +14 more
doaj   +1 more source

Re chronic stable angina guidelines

Indian Heart Journal, 2017
Prabha Nini Gupta, Praveen Velappan, Krishna Kumar Bhaskara Pillai, Riyas Abdul Salam   +3 more
doaj   +1 more source

Dynamics of proinflammatory cytokines level in stable angina (II–III functional class)

Сеченовский вестник, 2016
The article discusses the evaluation of cytokine level (IL-1β, IL-6) in patients with II–III functional class stable angina. In the group of patients with II–III class stable angina, the standard therapy failed to normalize the level of proinflammatory ...
E. K. Gordeeva, A. H. Kade, S. A. Zanin
doaj  

CARDIOPROTECTION POTENTIAL IN CORONARY HEART DISEASE TREATMENT

Российский кардиологический журнал, 2009
Aim. To investigate effectiveness and safety of trimetazidine MB in the complex treatment of stable angina. In total, 90 patients were examined – 57 women and 33 men aged 48-70 years (mean age 61,4 ± 6,03 years).
N. A. Shostak, O. G. Smolenskaya, A. V. Panov, A. A. Klimenko, D. Yu. Andriyashkina, N. A. Tverdova   +5 more
doaj  

Effectiveness and Tolerability of Trimetazidine 80 mg Once Daily in Patients with Chronic Coronary Syndrome in Brazil: The V-GOOD Observational Study

Cardiology and Therapy
Introduction The V-GOOD study evaluated the effectiveness of trimetazidine modified-release (MR) 80 mg once daily (OD) in patients with chronic coronary syndrome (CCS) who remained symptomatic despite antianginal therapies in routine clinical practice ...
Luís Henrique Wolff Gowdak, Paulo Magno Martins Dourado, Dalton Bertolim Précoma, César de Oliviera Lopes Dusilek, Francisco Maia da Silva, Juan Carlos Yugar-Toledo, Felipe Montes Pena, Domingos Antônio de Almeida Gomes, Elizabeth do Espírito Santo Cestário, Olavo Raimundo Guimarães, Conrado Roberto Hoffmann Filho, Carlos Filinto de Almeida, Flávio de Souza Brito, Gerez Fernandes Martins, Victor Rodrigues Ribeiro Ferreira, Marcella Chaves Flores, Mayara Lídia da Silva, on behalf of the V-GOOD Investigators   +17 more
doaj   +1 more source